Online citations, reference lists, and bibliographies.
← Back to Search

Pharmacokinetics Of Nanomaterials: An Overview Of Carbon Nanotubes, Fullerenes And Quantum Dots.

J. Riviere
Published 2009 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A full understanding of the pharmacokinetic parameters describing nanomaterial disposition in the body would greatly facilitate development of a firm foundation upon which risk assessment could be based. This review focuses on the disposition of carbon based fullerenes and nanotubes, as well as quantum dots (QD) after parenteral administration to primarily rodents. The common theme across all particle types is that a major determinant of nanomaterial disposition is the degree of interaction with the reticuloendothelial (RE) cell system. Small water-soluble particles evading this system may be excreted by the kidney. Larger particles and those with the proper surface charge may get targeted to RE cells in the liver, spleen and other organs. Most nanomaterial kinetics are characterized by relatively short blood half-lives reflecting tissue extraction and not by clearance from the body. In fact, another common attribute to nanomaterial kinetics is retention of particles in the body. Finally, unlike many small organic drugs, nanomaterials may preferentially be trafficked in the body via the lymphatic system that has obvious immunological implications.
This paper references
10.1002/JPS.2600780708
Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap.
P. L. Williams (1989)
10.1016/1074-5521(95)90219-8
In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity.
S. Yamago (1995)
10.1006/BIOO.1996.0032
Tissue Sites of Uptake of14C-Labeled C60
Rebecca Bullard-Dillard (1996)
10.1128/AAC.40.10.2262
Pharmacokinetics of a water-soluble fullerene in rats
P. Rajagopalan (1996)
10.1002/9780470959916
Comparative Pharmacokinetics: Principles, Techniques, and Applications
J. Riviere (1999)
10.1073/PNAS.96.9.5182
In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.
D. W. Cagle (1999)
10.1016/S0169-409X(00)00121-6
Lymphatic targeting with nanoparticulate system.
Y. Nishioka (2001)
10.1016/S0169-409X(01)00153-3
Lymphatic transport of proteins after s.c. injection: implications of animal model selection.
C. J. Porter (2001)
10.1080/00984100290071649
TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW
W. Kreyling (2002)
10.1073/pnas.152463399
Nanocrystal targeting in vivo
M. Akerman (2002)
10.1016/S0969-8051(02)00313-X
Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies.
Li Qingnuan (2002)
10.1080/1061186031000086108
In Vitro and In Vivo Study of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
E. Peira (2003)
10.1038/nbt920
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
S. Kim (2004)
10.1021/BC034153Y
Noninvasive imaging of quantum dots in mice.
B. Ballou (2004)
10.1023/A:1025036611949
Pharmacokinetic Model to Describe the Lymphatic Absorption of r-metHu-Leptin After Subcutaneous Injection to Sheep
Danielle N. McLennan (2004)
10.1016/J.ATHORACSUR.2004.06.055
Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots.
E. Soltesz (2005)
10.1124/JPET.104.078790
Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep
Danielle N. McLennan (2005)
10.1007/S11051-005-9001-5
Biodistribution and tumor uptake of C60(OH)x in mice
Z. Ji (2006)
10.1073/PNAS.0509009103
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
10.1073/pnas.0609265103
Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence
P. Cherukuri (2006)
10.1002/ADFM.200500529
Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat†
H. Fischer (2006)
10.1007/S11051-005-9068-Z
Health implications of nanoparticles
W. Kreyling (2006)
10.2967/jnumed.107.040071
microPET-Based Biodistribution of Quantum Dots in Living Mice
M. L. Schipper (2007)
10.1289/ehp.10290
Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment
R. Yang (2007)
10.1088/0953-8984/19/37/373101
Carbon nanomaterials in biological systems
P. Ke (2007)
10.1016/J.NANO.2007.09.001
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
L. Balogh (2007)
Pharmacometrics : the science of quantitative pharmacology
E. Ette (2007)
10.1021/NL071563C
Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction.
H. A. Lee (2007)
10.1093/TOXSCI/KFM074
Migration of intradermally injected quantum dots to sentinel organs in mice.
N. Gopee (2007)
10.1016/J.NUCMEDBIO.2007.03.003
Biodistribution of functionalized multiwall carbon nanotubes in mice.
Jin-xue Guo (2007)
10.1038/nnano.2006.170
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice.
Z. Liu (2007)
10.1002/JPS.20875
Role of nanotechnology in pharmaceutical product development.
H. Devalapally (2007)
10.1016/J.CARBON.2007.03.035
Translocation and fate of multi-walled carbon nanotubes in vivo
Xiaoyong Deng (2007)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1093/TOXSCI/KFM217
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
D. Dutta (2007)
10.3109/9781420045154-10
Pharmacokinetics of Nanomaterials
J. Riviere (2007)
Nanoscaled carriers: nanomedicine for the improved delivery of drugs across biological barriers
CM Lehr (2007)
10.1021/bc700477u
Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.
G. Xu (2008)



This paper is referenced by
10.1016/j.lfs.2021.119020
Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer.
K. Mortezaee (2021)
10.1007/978-981-15-9627-8_5
Carbon Nanotubes—Potential of Use for Deep Bioimaging
Atsuto Onoda (2021)
10.1007/978-981-15-9627-8
Transparency in Biology: Making the Invisible Visible
K. Soga (2021)
10.2147/IJN.S291670
Water-Soluble Carbon Dots in Cigarette Mainstream Smoke: Their Properties and the Behavioural, Neuroendocrinological, and Neurotransmitter Changes They Induce in Mice
Yan Zhao (2021)
10.3390/nano10010143
Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene
Nicholas G Zaibaq (2020)
10.3390/nano10020400
Safe Administration of Carbon Nanotubes by Intravenous Pathway in BALB/c Mice
José Jesús Guzmán-Mendoza (2020)
10.1002/adhm.202000730
Nanomaterial Additives for Fabrication of Stimuli-Responsive Skeletal Muscle Tissue Engineering Constructs.
Amy Corbin Farr (2020)
10.1038/s41598-020-75123-4
An in-silico layer-by-layer adsorption study of the interaction between Rebaudioside A and the T1R2 human sweet taste receptor: modelling and biosensing perspectives
Olayide A. Arodola (2020)
10.1039/d0gc00734j
Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: current challenges and future perspectives
Ghazaleh Jamalipour Soufi (2020)
10.1080/00498254.2018.1528646
Disposition of fullerene C60 in rats following intratracheal or intravenous administration
K. Shipkowski (2019)
10.1124/jpet.118.256230
Translating Nanomedicine to Comparative Oncology—the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer
R. DeLong (2019)
10.1016/J.MOLLIQ.2019.01.085
Nonspecific nanocarriers for doxorubicin and cytarabine in the presence of fatted and defatted human albumin. Part I
D. Pentak (2019)
10.21533/PEN.V7I3.799
Kinetic profile of silver and zinc oxide nanoparticles by intraperitoneal injection in mice , a comparative study
Sarab Mohammed M. Razooki (2019)
10.1080/17435390.2019.1595206
Application of Bayesian networks in determining nanoparticle-induced cellular outcomes using transcriptomics
I. Furxhi (2019)
10.1080/17435390.2018.1476986
Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona
J. Riviere (2018)
10.1039/C8EN00572A
Emerging investigator series: the dynamics of particle size distributions need to be accounted for in bioavailability modelling of nanoparticles
M. Vijver (2018)
10.1016/j.pneurobio.2017.10.003
Nano- and neurotoxicology: An emerging discipline
A. Bencsik (2018)
10.1002/etc.4253
An assessment of applicability of existing approaches to predicting the bioaccumulation of conventional substances in nanomaterials.
W. Utembe (2018)
10.1016/j.impact.2017.03.003
Biokinetics of Nanomaterials: the Role of Biopersistence.
P. Laux (2017)
10.1080/17435390.2016.1264638
Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity
K. Choi (2017)
Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models
E. Burello (2017)
10.1201/9781315371795-22
The Safety of Nanomaterials on Molecular and Cellular Scale
A. Kraegeloh (2017)
10.1016/j.tiv.2017.04.020
Biocorona formation on gold nanoparticles modulates human proximal tubule kidney cell uptake, cytotoxicity and gene expression.
M. T. Ortega (2017)
10.1016/J.IMPACT.2016.12.006
Generation and characterization of aerosols released from sanding composite nanomaterials containing carbon nanotubes
J. Kang (2017)
10.1016/B978-0-12-809717-5.00014-2
Carbon Nanotubes in Targeting and Delivery of Drugs
Rakesh K Tekade (2017)
10.1080/10408444.2017.1328400
A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials
W. Boyes (2017)
10.1007/978-3-319-32392-3_11
A Bayesian Regression Methodology for Correlating Noisy Hazard and Structural Alert Parameters of Nanomaterials
Eamonn M. McAlea (2016)
10.1002/9783527692866.CH3
Biodistribution and Pharmacokinetics of Carbon Nanomaterials In Vivo
Sheng-Tao Yang (2016)
10.3109/17435390.2015.1027314
A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice
Z. Lin (2016)
10.2147/IJN.S109950
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo
Elisa Principi (2016)
10.1016/j.envint.2016.07.016
Frameworks and tools for risk assessment of manufactured nanomaterials.
D. Hristozov (2016)
10.2174/1874325001610010877
Carbon Nanostructures in Bone Tissue Engineering
B. Perkins (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar